UNICELL-2019-nCoV NAb (Neutralization Antibody) assay is a Fluorescent Immunoassays (FIA) for the quantitative determination of 2019-nCoV Neutralization Antibodies in human serum or plasma. This assay can simulate the in vivo binding of SARS-CoV-2 RBD to ACE2-receptor in human host cells after SARS-CoV-2 infection or vaccination.
UNICELL-2019-nCoV NAb (Neutralization Antibody) assay is a Fluorescent Immunoassays (FIA) for the quantitative determination of 2019-nCoV Neutralization Antibodies in human serum or plasma. This assay can simulate the in vivo binding of SARS-CoV-2 RBD to ACE2-receptor in human host cells after SARS-CoV-2 infection or vaccination.
Features:
●Convenient: Easy operation with minimal maintainence required
●Automation: Perform Neutralization Antibody test on a standardized POCT platform
●Testing Flexibility: Flexible testing capacity, first result within 15 minutes,3 different test modes